Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axitinib for downstaging large renal tumors (AXIPAN)
NCT02597322Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2012
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of axitinib in renal cell carcinoma (RCC), sponsored by Assistance publique - Hôpitaux de Paris. Started Feb 2012; status: completed.
02
Drugs
axitinib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT02597322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02597322.